Sally has wealth of experience working with businesses at the cutting edge of research and technology, and whose intellectual property is of prime importance.
Sally is one of the firm’s leading intellectual property (IP) partners. She provides a full range of intellectual property commercial advice and support to her clients, including licensing, partnering and exploitation agreements, research, development and marketing collaborations. She also frequently advises clients on regulatory and ‘freedom to operate’ matters, and manages significant due diligence matters. As a transactional intellectual property lawyer, she provides advice in relation to the protection and exploitation of a full range of IP rights, both in stand alone transactions and as part of an acquisition, divestment or investment activity.
Before joining us in 2006, Sally was head of IP and life sciences at Eversheds, and prior to that she spent 11 years working in-house firstly as senior legal adviser at ICI/Zeneca and latterly as legal director of Novartis UK. This in-house experience gave her significant insight into the need to give pragmatic and commercial advice.
Sally was one of eight pharmaceutical licensing experts drawn from around the world to work together with representatives from UNITAID and WIPO at a workshop to determine the licensing provisions for the supply of drugs to third-world countries.
Chambers UK (2016) says: “Sally Shorthose leads the firm's commercial and transactional IP work and is a life sciences sector stalwart. A client says: ‘I have appreciated her practical and business-minded approach to our legal issues’."
IAM Patent 1000 (2015) says: "When it comes to transactions, Sally Shorthose is the obvious choice: she was previously the legal director of Novartis UK and has worked on global licensing projects for the United Nations."
WWL says: She is praised for her “particularly strong awareness of commercial issues that life sciences companies need to consider”
This biography is an extract from Who's Who Legal: Life Sciences which can be purchased from our Shop.
It is not possible to buy entry into any Who's Who Legal publication
Nominees have been selected based upon comprehensive, independent survey work with both general counsel and private practice lawyers worldwide. Only specialists who have met independent international research criteria are listed.